Kuloglu T, Aydin S
Departments of Histology and Embryology.
Biotech Histochem. 2014 Feb;89(2):104-10. doi: 10.3109/10520295.2013.821713. Epub 2013 Aug 19.
Diabetes is characterized by high blood glucose levels; it occurs in 30-35% of the population. Elevated glucose levels can damage a number of organs, including the kidneys. Several peptide hormones participate in maintaining glucose homeostasis including the recently discovered "adropin," a 42 amino acid peptide hormone. Adropin also alters inducible nitric oxide synthase (iNOS) expression. Therefore, we studied how adropin and iNOS expression is altered in the renal tissues of streptozotocin (STZ) induced diabetic rats. Seven sham, seven control and seven Wistar albino male rats were fed standard rat pellets and water ad libitum for 10 weeks. The rats in the diabetic group were injected i.p. with a single dose of 60 mg/kg STZ dissolved in 0.1 M phosphate-citrate buffer, pH 4.5. After the 10-week experimental period, the rats in both groups were anesthetized and decapitated. Kidney tissues were excised and placed in 10% formaldehyde solution, taken through routine histological procedures, and embedded in paraffin. Sections 5-6 μm thick were stained immunohistochemically using the avidin-biotin complex (ABC) method. Adropin and iNOS immunoreactivity were co-localized in the glomeruli, peritubular interstitial cells and peritubular capillary endothelium of the cortex; the thin limb of the loop of Henle in the medulla; and medullary peritubular interstitial cells and endothelium of the peritubular capillaries in both the control and diabetic groups. The intensities of adropin and iNOS immunoreactivity increased with the severity of the diabetes. Intense adropin immunoreactivity was detected in both the smooth muscle and human small intestine Paneth cells that were used as positive controls. The elevated levels of adropin and iNOS in the kidney indicates that these substances are involved in the pathophysiology of diabetes; this constitutes a compensatory mechanism against the damage inflicted by the disease.
糖尿病的特征是血糖水平升高;在30 - 35%的人群中会发生。血糖水平升高会损害包括肾脏在内的许多器官。几种肽类激素参与维持葡萄糖稳态,包括最近发现的“内脂素”,一种由42个氨基酸组成的肽类激素。内脂素还会改变诱导型一氧化氮合酶(iNOS)的表达。因此,我们研究了链脲佐菌素(STZ)诱导的糖尿病大鼠肾组织中内脂素和iNOS表达是如何改变的。七只假手术组、七只对照组和七只Wistar白化雄性大鼠自由进食标准大鼠颗粒饲料和饮水10周。糖尿病组大鼠腹腔注射单剂量60 mg/kg溶解于pH 4.5的0.1 M磷酸 - 柠檬酸盐缓冲液中的STZ。经过10周的实验期后,两组大鼠均麻醉后断头。切除肾脏组织并置于10%甲醛溶液中,经过常规组织学程序处理,然后包埋在石蜡中。使用抗生物素蛋白 - 生物素复合物(ABC)方法对5 - 6μm厚的切片进行免疫组织化学染色。内脂素和iNOS免疫反应性在皮质的肾小球、肾小管周围间质细胞和肾小管周围毛细血管内皮中共定位;髓质中髓袢细段;以及对照组和糖尿病组的髓质肾小管周围间质细胞和肾小管周围毛细血管内皮。内脂素和iNOS免疫反应性的强度随糖尿病严重程度增加。在用作阳性对照的平滑肌和人小肠潘氏细胞中均检测到强烈的内脂素免疫反应性。肾脏中内脂素和iNOS水平升高表明这些物质参与了糖尿病的病理生理学过程;这构成了针对该疾病造成的损害的一种代偿机制。